[Pulmonary hypertension clinical pathway: ANMCO Tuscany Board model].

Clinical pathway per l’ipertensione polmonare: la proposta di ANMCO Toscana.

Journal

Giornale italiano di cardiologia (2006)
ISSN: 1972-6481
Titre abrégé: G Ital Cardiol (Rome)
Pays: Italy
ID NLM: 101263411

Informations de publication

Date de publication:
Mar 2023
Historique:
entrez: 28 2 2023
pubmed: 1 3 2023
medline: 3 3 2023
Statut: ppublish

Résumé

Pulmonary hypertension (PH) is defined by a mean pulmonary artery pressure >20 mmHg at rest during right heart catheterization. PH prevalence is about 1% of the global population. The PH clinical classification includes five groups: pulmonary arterial hypertension, PH associated with left heart disease, PH associated with lung disease, PH associated with pulmonary artery obstructions, PH with unclear and/or multifactorial mechanisms. In case of clinical suspicion, echocardiography is the first-line tool to start the diagnostic process. Right heart catheterization is the gold standard for diagnosis of PH, requires great experience and should be performed in expert centers. The classification of the PH patient in a specific subgroup requires multidisciplinary clinical and instrumental skills that only a reference center can provide. This document proposes a clinical pathway for the management of PH patients in the Tuscany region in order to standardize access to specialized care.

Identifiants

pubmed: 36853154
doi: 10.1714/3980.39620
doi:

Types de publication

English Abstract Journal Article

Langues

ita

Sous-ensembles de citation

IM

Pagination

178-187

Auteurs

Gaia Spaziani (G)

Meyer Children's Hospital IRCCS, Firenze.

Simonetta Monti (S)

Fondazione Toscana Gabriele Monasterio, Pisa - Istituto di Fisiologia Clinica del CNR, Pisa.

Leonardo Misuraca (L)

U.O.S.D. Cardiologia Interventistica, Ospedale della Misericordia, Grosseto.

Edoardo Airò (E)

Fondazione Toscana Gabriele Monasterio, Pisa.

Anna Maria Traini (AM)

U.O. Cardiologia, Ospedale Santo Stefano, Prato.

Carolina Bauleo (C)

Fondazione Toscana Gabriele Monasterio, Pisa.

Maria Laura Canale (ML)

Cardiologia, Ospedale Versilia, Azienda USL Toscana Nord Ovest, Lido di Camaiore (LU).

Marisa Carluccio (M)

U.O. Cardiologia 2, Azienda Ospedaliero Universitaria Pisana, Pisa.

Gabriele Grippo (G)

U.O.C. Cardiologia, Ospedale Santo Stefano, Prato.

Gaia Chiara Selvaggia Magnaghi (GC)

U.O. Cardiologia, Ospedale SS. Cosma e Damiano, Pescia (PT).

Francesco Orso (F)

S.O.D.c. Geriatria-UTIG, Azienda Ospedaliero-Universitaria Careggi, Firenze.

Carlotta Sorini Dini (C)

Cardiologia Clinica-Chirurgia/UTIC, Azienda Ospedaliero Universitaria Senese, Siena.

Enrica Talini (E)

U.O.C. Cardiologia, Ospedale di Livorno.

Rosa Poddighe (R)

Cardiologia, Ospedale Versilia, Azienda USL Toscana Nord Ovest, Lido di Camaiore (LU).

Andrea Picchi (A)

U.O.S.D. Cardiologia Interventistica, Ospedale della Misericordia, Grosseto.

Ugo Limbruno (U)

U.O.C. Cardiologia, Ospedale della Misericordia, Grosseto.

Silvia Favilli (S)

Meyer Children's Hospital IRCCS, Firenze.

Giancarlo Casolo (G)

Cardiologia, Ospedale Versilia, Azienda USL Toscana Nord Ovest, Lido di Camaiore (LU).

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH